Pathological conformations involving the amino terminus of tau occur early in Alzheimer's disease and are differentially detected by monoclonal antibodies
Open Access
- 1 October 2016
- journal article
- Published by Elsevier in Neurobiology of Disease
- Vol. 94, 18-31
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Phosphorylation in the amino terminus of tau prevents inhibition of anterograde axonal transportNeurobiology of Aging, 2012
- Heat Shock Protein 70 Prevents both Tau Aggregation and the Inhibitory Effects of Preexisting Tau Aggregates on Fast Axonal TransportBiochemistry, 2011
- Pathogenic Forms of Tau Inhibit Kinesin-Dependent Axonal Transport through a Mechanism Involving Activation of Axonal PhosphotransferasesThe Journal of Neuroscience, 2011
- Characterization of Prefibrillar Tau Oligomers in Vitro and in Alzheimer DiseaseJournal of Biological Chemistry, 2011
- Structural Polymorphism of 441-Residue Tau at Single Residue ResolutionPLOS Biology, 2009
- The amino terminus of tau inhibits kinesin‐dependent axonal transport: Implications for filament toxicityJournal of Neuroscience Research, 2008
- Tau Suppression in a Neurodegenerative Mouse Model Improves Memory FunctionScience, 2005
- Tau Conformational Changes Correspond to Impairments of Episodic Memory in Mild Cognitive Impairment and Alzheimer's DiseaseExperimental Neurology, 2002
- Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205Neuroscience Letters, 1995
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991